rhNRG-1

DRUG6 trials

Sponsors

Zensun Sci. & Tech. Co., Ltd.

Conditions

Chronic Heart FailureChronic Systolic Heart Failure

Phase 3

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

TerminatedNCT01131637

Zensun Sci. & Tech. Co., Ltd.Chronic Heart Failure

Start: 2010-04-30End: 2012-08-31Updated: 2017-12-21

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

TerminatedNCT01214096

Zensun Sci. & Tech. Co., Ltd.Chronic Heart Failure

Start: 2010-07-31End: 2011-01-31Updated: 2017-12-21

Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients

TerminatedNCT01439789

Zensun Sci. & Tech. Co., Ltd.Chronic Heart Failure

Start: 2011-06-30End: 2012-06-30Updated: 2017-12-21

Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients

TerminatedNCT01439893

Zensun Sci. & Tech. Co., Ltd.Chronic Systolic Heart Failure

Start: 2011-06-30End: 2012-06-30Updated: 2017-12-21

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

TerminatedNCT01541202

Zensun Sci. & Tech. Co., Ltd.Chronic Heart Failure

Start: 2012-02-29End: 2017-08-31Updated: 2017-12-21

Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

RecruitingNCT03388593

Zensun Sci. & Tech. Co., Ltd.Chronic Heart Failure

Start: 2018-07-23End: 2026-02-28Target: 1600Updated: 2024-02-01